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Reprogramming was performed using episomal vector delivery of OCT4, SOX2, KLF4, L-MYC, LIN28 and shRNA
for p53.
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Epidermal ﬁbroblasts were obtained from skin biopsies of a 50 years
old healthymale subject (EPS1133). Reprogrammingwas performed on
patient ﬁbroblasts using non-integrating episomal vectors to deliver
OCT4, SOX2, KLF4, L-MYC, LIN28 and shRNA to p53 (Piao et al., 2014;
Wang et al., 2016). A clonal hiPSC line (CERAi001-A-6 hiPSC) was
established and further characterized for pluripotency.
Characterization of CERAi001-A-6 hiPSCs demonstrated that the
cells were positive for the pluripotent markers TRA-1-60 and OCT4
(Fig. 1A and B, respectively). Upon embryoid body formation,
CERAi001-A-6 hiPSCs differentiated into cells representative of ecto-
derm (NESTIN positive cells, Fig. 1C), mesoderm (SMA positive cells,
Fig. 1D) and endoderm (AFP positive cells, Fig. 1E). RT-PCR analysis
demonstrated gene expression of NANOG and endogenous OCT4 and
SOX2, suggesting successful reprogramming of CERAi001-A-6 hiPSCs
(Fig. 1F). Altogether, these results demonstrate that the CERAi001-A-6
hiPSCs retain the potential to differentiate in vitro into the three germ
layers. To ensure the genetic integrity of the CERAi001-A-6 hiPSCs gen-
erated, we performed genome-wide copy number variation (CNV) pro-
ﬁling using Illumina HumanCore Beadchip. Our results demonstrate
that the parental ﬁbroblasts and CERAi001-A-6 hiPSCs were both male
(XY) and exhibited a normal diploid chromosomal content (Fig. 1G).
Furthermore, microsatellite analysis conﬁrmed that the CERAi001-A-6
hiPSCs originated from the parental patient ﬁbroblasts (Fig. 1H). The
established CERAi001-A-6 is negative for mycoplasma testing (Fig. 1I).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Characterization of CERAi001-A-6hiPSCs. Immunocytochemistry of A) TRA-1-60 and B)OCT4 inCERAi001-A-6hiPSCs. Following embryoid body differentiation, cells representative
of the three germ layers were detected, including C) ectodermal (NESTIN-positive), D) mesodermal (SMA-positive) and E) endodermal (AFP-positive) cells. (C–E): DAPI counterstained
(blue). Scale bars=100 μm. F) RT-PCR showed expression of endogenousOCT4, SOX2 andNANOG in CERAi001-A-6 hiPSCs andH9human embryonic stem cells, but absent in BJﬁbroblasts
and control without reverse transcriptase (-RT). G) CNV analysis conﬁrmed a normal diploid karyotype in CERAi001-A-6 hiPSCs. H) Heatmap of microsatellite analysis using 12
polymorphic markers conﬁrmed that CERAi001-A-6 hiPSCs originated from the parental patient ﬁbroblasts. I) CERAi001-A-6 hiPSCs is negative for mycoplasma contamination.
MycoAlert ratio of N1.2 is considered positive for mycoplasma.
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Ethics
Collection of patient samples and generation of hiPSCs were ap-
proved by theHumanResearchEthics committees of the Royal Victorian
Eye and Ear Hospital (11/1031H, 13/1151H-004) and carried out in ac-
cordance with the requirements of the National Health & Medical Re-
search Council of Australia and conformed with the Declarations of
Helsinki (McCaughey et al., 2016).Cell culture
Patient ﬁbroblasts were cultured in DMEM medium supplemented
with 10% fetal calf serum, 1 × L-glutamine, 0.1 mM non-essential amino
acids and 0.5× penicillin/streptomycin (all from Invitrogen). CERAi001-A-
6 hiPSCs were cultured on mitotically inactivated mouse embryonic ﬁbro-
blasts feeders in the presence of DMEM/F-12 medium containing 1 x
GlutaMAX, 20% knockout serum replacement, 10 ng/ml basic ﬁbroblast
growth factor, 0.1 mM nonessential amino acids, 100 μM β-
mercaptoethanol and 0.5× penicillin/streptomycin (all from Invitrogen).
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Skin ﬁbroblastswere reprogrammed to generate hiPSCs as previous-
ly described (Piao et al., 2014; Hung et al., 2016). Brieﬂy, 600,000 skin
ﬁbroblasts was nucleofected with episomal vectors (pCXLEhOCT3/4-
shp53, pCXLE-hSK, pCXLE-hUL, all from Addgene), using the
Nucleofection kit for primary ﬁbroblasts with program T-016 (Lonza).
The nucleofected cells were plated down onto gelatinized plate in ﬁbro-
blast medium. On day 7, 100,000 ﬁbroblasts were replated onto a
100 mm dish with MEF with hiPSC medium. On day 34 post-
reprogramming, we isolated hiPSC colonies by manual dissection. The
established CERAi001-A-6 hiPSCs were further expanded and charac-
terized for pluripotency (Wong et al., 2011). RT-PCR is performed to an-
alyse NANOG, endogenous OCT4 and SOX2 expression using the
following primers: OCT4-ENDO: GACAGGGGGAGGGGAGGAGCTAGG,
CTTCCCTCCAACCAGTTGCCCCAAAC; SOX2-ENDO: GGGAAATGGGAG
GGGTGCAAAAGAGG, TTGCGTGAGTGTGGATGGGATTGGTG; NANOG:
CAGCCCCGATTCTTCCACCAGTCCC, CGGAAGATTCCCAGTCGGGTTCACC;
β-ACTIN: CCCTGGCACCCAGCAC, GCCGATCCACACGGAGTAC. CNV anal-
ysis was performed using the Illumina HumanCore Beadchip SNP
array. Both the parental ﬁbroblasts and CERAi001-A-6 hiPSCs were
used for CNV analysis.
For in vitro differentiation, CERAi001-A-6 hiPSCs were allowed to
form embryoid bodies in suspension for 12 days, followed by attach-
ment on gelatinized dishes for further differentiation for 15 days. Differ-
entiation markers (SMA, NESTIN and AFP) were analysis to detect cell
representative of the three germ layers.
Immunocytochemistry
Immunocytochemistry analysis was performed using standard pro-
cedures. Samples were immunostained with primary antibodies TRA-
1-60 (5 μg/ml, MAB4360, Millipore), OCT4 (5 μg/ml, sc-5279, Santa
Cruz Biotechnology), SMA (10 μg/ml, MAB1420, R&D Systems), NESTIN
(10 μg/ml, AB22035, Abcam) or AFP (10 μg/ml, ST1673, Millipore).Subsequently, the samples were immunostained by the appropriate
Alexa Fluor-488 antibodies and DAPI nuclear counterstain. Fluorescent
images were taken using a Nikon Eclipse TE2000 inverted microscope.
Microsatellite analysis
Microsatellite analysis was performed using the Applied Biosystems
Linkage Mapping Set (Australian Genomics Research Facility). Twelve
polymorphic markers were assessed, including D2S2211, D2S125,
D2S337, D3S1267, D6S257, D8S284, D11S904, D11S4151, D12S78,
D12S345, D14S283 and D17S1852. The results were presented as a
heatmap using R.
Mycoplasma testing
Mycoplasma test is performed using the MycoAlert kit (Lonza)
following the manufacturer's instruction.
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